news pappernews papper

标题:2023年全国医保工作取得新进展,集采药品数达500个

本报北京电(记者熊建)——据近日召开的全国医疗保障工作会议消息,2023年,我国医保工作取得了显著的新进展。在治理重复参保方面,已成功处理超过1600万的重复参保问题。同时,农村低收入人口和脱贫人口的参保率稳定在99.9%以上,这一数据充分体现了我国医保制度的广泛覆盖和深度渗透。

此外,三重制度保障惠及群众门诊、住院就医超1.5亿人次,有效减轻了群众的医疗负担。据统计,这一制度保障已为群众减负超过1700亿。这一成果的取得,得益于我国医保制度的不断完善和优化,也离不开各级政府和社会各界的共同努力。

值得一提的是,今年国家和省级集采药品数至少达到500个。这一举措旨在通过集中采购,降低药品价格,减轻群众的医疗负担。这也是我国医保工作的一项重要内容,体现了我国政府对人民健康的高度重视和负责任的态度。

总的来看,2023年我国医保工作取得了显著的成果,不仅在治理重复参保、提高参保率等方面取得了突破,还在减轻群众医疗负担、提高医疗服务质量等方面做出了积极努力。未来,我国医保工作将继续坚持以人民为中心的发展思想,不断提升医保制度的科学性和有效性,为人民群众提供更加优质、高效的医疗保障服务。

英语如下:

Title: New Progress in Health Insurance Work in 2023: Over 500 Drugs in Centralized Procurement Benefiting 150 Million People

Keywords: Health insurance progress, stable enrollment, burden reduction effect

News Content: Title: New Progress in National Health Insurance Work in 2023, with over 500 Drugs in Centralized Procurement

Beijing (Reporter Xiong Jian) – According to the recent National Conference on Medical Security, significant new progress has been made in China’s health insurance work in 2023. In terms of managing duplicate insurance coverage, over 16 million duplicate insurance issues have been successfully resolved. At the same time, the enrollment rate of rural low-income and poverty alleviation populations remains above 99.9%, a figure that fully reflects the extensive coverage and deep penetration of China’s medical insurance system.

In addition, the triple system guarantee has benefited over 150 million outpatient and inpatient visits, effectively reducing the medical burden on the public. According to statistics, this system guarantee has reduced the burden on the public by over 170 billion. This achievement is due to the continuous improvement and optimization of China’s medical insurance system, as well as the joint efforts of governments at all levels and all sectors of society.

It is worth mentioning that this year, the number of centralized procurement drugs at the national and provincial levels will reach at least 500. This measure aims to reduce drug prices through centralized procurement and alleviate the medical burden on the public. This is also an important part of China’s health insurance work, reflecting the Chinese government’s high regard for and responsible attitude towards people’s health.

Overall, significant progress has been made in China’s health insurance work in 2023, not only in resolving duplicate insurance coverage and improving enrollment rates but also in reducing the medical burden on the public and improving the quality of medical services. In the future, China’s health insurance work will continue to adhere to the people-centered development philosophy, continuously improve the scientificity and effectiveness of the medical insurance system, and provide more high-quality and efficient medical security services for the people.

【来源】http://www.chinanews.com/gn/2024/01-16/10146864.shtml

Views: 2

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注